Q3 2026
Read transcript →Intensity Therapeutics, Inc. (INTS) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$2.94
-4.67%
Mkt Cap $14.65M
Q2 2026
Read transcript →NASDAQ·Healthcare·Biotechnology
$2.94
-4.67%
Mkt Cap $14.65M
Q3 2026
Read transcript →Q2 2026
Read transcript →